Home > Insider Trading > Filing (0001209191-22-037401)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	Pharmaceutical Preparations (2834)	812744449

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1872792	Sean Grant	C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2022-06-15	2,816	$13.60	2,816	No	4	P	Indirect	By IRA
Class A Common Stock	Acquisiton	2022-06-15	335	$13.60	335	No	4	P	Indirect	By Roth IRA
Class A Common Stock	Acquisiton	2022-06-15	857	$13.60	857	No	4	P	Indirect	By Spouse's IRA
Class A Common Stock	Acquisiton	2022-06-15	992	$13.60	992	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By IRA
No	4	P	Indirect	By Roth IRA
No	4	P	Indirect	By Spouse's IRA
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	1,518	Direct

Footnotes

These shares were purchased in multiple transactions for all of Reporting Person's indirect accounts on the reported date with prices ranging from $13.05 to $13.85, resulting in a weighted average price of $13.6008. Upon request, the Reporting Person will provide to Issuer, the Commission staff or a security holder of the Issuer the number of shares purchased and the purchase price for each separate transaction.
Shares acquired under the Issuer's Employee Stock Purchase Plan on March 11, 2022.